CVX vs DHR: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Chevron Corporation · Energy
$193.33
-13.1% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
CVX trades at a lower forward P/E
(31.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
DHR |
| Current Price |
$193.33 |
$174.04 |
| Fair Value Estimate |
$168.03 |
$197.01 |
| Upside to Fair Value |
-13.1%
|
+13.2%
|
| Market Cap |
$385.8B |
$123.2B |
| Forward P/E |
31.3x
|
33.4x
|
| EV / EBITDA |
10.3x
|
20.3x
|
| Price / Sales |
2.1x
|
5.0x
|
| Price / FCF |
23.8x
|
23.3x
|
| Revenue Growth YoY |
-5.3%
|
+3.7%
|
| Gross Margin |
30.4%
|
60.7%
|
| Operating Margin |
9.0%
|
21.0%
|
| Return on Equity |
7.3%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.19%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company with significant upstream and downstream operations. The company benefits from experienced leadership under CEO Mike Wirth, who has over 44 years with Chevron, and maintains a strong market position as the second largest Big Oil major by market cap and net profits. However, Chevron currently trades at a very expensive valuat…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
CVX |
DHR |
| Zone Low |
$126.02 |
$147.76 |
| Zone High |
$142.83 |
$167.46 |
| In Buy Zone? |
No
|
No
|